Live Quote · NYSEBXFinancial Services· Asset Management

Blackstone Inc.

$123.59 2.62%($-3.32)
TickerSpark Score
67/100
Solid
53
Valuation
95
Profitability
75
Growth
64
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BX research report →

52-Week Range25% of range
Low
$101.73
Current
$123.59
High
$190.09
Company Overviewwww.blackstone.com

About the company

Blackstone Inc. operates as a prominent alternative asset manager, specializing in a broad spectrum of investment strategies. Its expertise encompasses real estate, private equity, credit solutions, comprehensive hedge fund offerings, public debt and equity, multi-asset class approaches, and secondary funds of funds.

CEO
Stephen Allen Schwarzman
IPO
2007
Employees
5,285
HQ
New York City, NY, US

Price Chart

-26.74% · this period
$188.68$145.40$102.12Jul 18Jan 16Jul 20
AI Analysis · BX

AI snapshot

Six angles, distilled from the data.

Technical Setup

BX is still in a long-term correction after trading well below its 200-day average, though the intermediate trend has improved with the shares back above the 50-day line. The stock remains far from its 52-week high and is working through a multi-month base rather than a clean uptrend.

Analyst Consensus

Street sentiment stays constructive: the consensus is Buy with a $149.86 target, above the recent close. Recent action has been mixed, with several fresh initiations and a Barclays cut to $119, but the broader target range still centers well above current levels.

Earnings Watch

Blackstone has a strong beat streak, with 7 straight EPS beats and the last four surprises ranging from 1.5% to 23.6%. Next quarter is set up against a 1.32 EPS estimate, and shareholders should watch whether fee-related earnings and deployment keep supporting the sharp step-up in full-year EPS expectations.

Insider Pulse

The pattern leans mildly positive after discretionary director buying in May, while the large officer sales look more like profit-taking than a broad exit. Most April entries are award grants and should be treated as compensation noise, not trading signal.

Financial Health

Profitability is strong, with a 38.0% operating margin, 21.2% net margin, and 29.5% ROE. Growth is steady rather than explosive, with revenue up 5.7% and earnings up 3.9% year over year, while free cash flow reached $1.98 billion in fiscal 2025.

Peer Snapshot

BX wins on scale, brand, and profitability in alternative asset management, with margins that many peers cannot match. The stock still trades at a premium profile versus the sector, supported by its 21.73 P/E and a market cap above $152 billion.

AI analysis · Last refreshed July 20, 2026 · Live quote · Not investment advice